Your browser doesn't support javascript.
loading
Dose-Dependent Effect of Platinum-Based Chemotherapy on the Risk of Metachronous Contralateral Testicular Cancer.
Blok, Joost M; Groot, Harmke J; Huele, Eline H; de Wit, Ronald; Horenblas, Simon; Nuver, Janine; Groenewegen, Gerard; Bosch, J L H Ruud; Witjes, J Alfred; Tromp, Jacqueline M; de Brouwer, Peter J M; van den Berg, Hetty A; Vanneste, Ben G L; Smilde, Tineke J; Aarts, Maureen J B; Gietema, Jourik A; Meijer, Richard P; Schaapveld, Michael.
Affiliation
  • Blok JM; Department of Oncological Urology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Groot HJ; Department of Urology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Huele EH; Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • de Wit R; Department of Oncological Urology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Horenblas S; Department of Medical Oncology, Erasmus University Hospital, Rotterdam, the Netherlands.
  • Nuver J; Department of Urology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Groenewegen G; Department of Medical Oncology, University Medical Center Groningen, Groningen, the Netherlands.
  • Bosch JLHR; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Witjes JA; Department of Oncological Urology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Tromp JM; Department of Urology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • de Brouwer PJM; Department of Medical Oncology, Amsterdam University Medical Center, Amsterdam, the Netherlands.
  • van den Berg HA; Department of Radiation Oncology, Dr Bernard Verbeeten Institute, Tilburg, the Netherlands.
  • Vanneste BGL; Catharina Hospital, Eindhoven, the Netherlands.
  • Smilde TJ; Department of Radiation Oncology, MAASTRO-clinic, Maastricht, the Netherlands.
  • Aarts MJB; Department of Medical Oncology, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands.
  • Gietema JA; Department of Medical Oncology, Maastricht University Medical Center+, Maastricht, the Netherlands.
  • Meijer RP; Department of Medical Oncology, University Medical Center Groningen, Groningen, the Netherlands.
  • Schaapveld M; Department of Oncological Urology, University Medical Center Utrecht, Utrecht, the Netherlands.
J Clin Oncol ; 39(4): 319-327, 2021 02 01.
Article in En | MEDLINE | ID: mdl-33119475

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Organoplatinum Compounds / Testicular Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Neoplasms, Second Primary / Neoplasms, Germ Cell and Embryonal Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Humans / Male Country/Region as subject: Europa Language: En Journal: J Clin Oncol Year: 2021 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Organoplatinum Compounds / Testicular Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Neoplasms, Second Primary / Neoplasms, Germ Cell and Embryonal Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Humans / Male Country/Region as subject: Europa Language: En Journal: J Clin Oncol Year: 2021 Document type: Article Affiliation country: Country of publication: